These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 21069102)

  • 21. Levetiracetam as add-on therapy for idiopathic generalized epilepsy syndromes with onset during adolescence: analysis of two randomized, double-blind, placebo-controlled studies.
    Rosenfeld WE; Benbadis S; Edrich P; Tassinari CA; Hirsch E
    Epilepsy Res; 2009 Jul; 85(1):72-80. PubMed ID: 19327967
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Levetiracetam monotherapy in children with epilepsy.
    Khurana DS; Kothare SV; Valencia I; Melvin JJ; Legido A
    Pediatr Neurol; 2007 Apr; 36(4):227-30. PubMed ID: 17437904
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Intravenous levetiracetam in the management of acute seizures in children.
    Reiter PD; Huff AD; Knupp KG; Valuck RJ
    Pediatr Neurol; 2010 Aug; 43(2):117-21. PubMed ID: 20610122
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Levetiracetam extended release and levetiracetam immediate release as adjunctive treatment for partial-onset seizures: an indirect comparison of treatment-emergent adverse events using meta-analytic techniques.
    Richy FF; Banerjee S; Brabant Y; Helmers S
    Epilepsy Behav; 2009 Oct; 16(2):240-5. PubMed ID: 19699156
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prospective assessment of levetiracetam pharmacokinetics during dose escalation in 4- to 12-year-old children with partial-onset seizures on concomitant carbamazepine or valproate.
    Fountain NB; Conry JA; Rodríguez-Leyva I; Gutierrez-Moctezuma J; Salas E; Coupez R; Stockis A; Lu ZS
    Epilepsy Res; 2007 Apr; 74(1):60-9. PubMed ID: 17270398
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Levetiracetam: a long-term follow-up study of efficacy and safety.
    Bauer J; Ben-Menachem E; Krämer G; Fryze W; Da Silva S; Kasteleijn-Nolst Trenité DG
    Acta Neurol Scand; 2006 Sep; 114(3):169-76. PubMed ID: 16911344
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Rapid infusion of a loading dose of intravenous levetiracetam with minimal dilution: a safety study.
    Wheless JW; Clarke D; Hovinga CA; Ellis M; Durmeier M; McGregor A; Perkins F
    J Child Neurol; 2009 Aug; 24(8):946-51. PubMed ID: 19264738
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Double-blind placebo-controlled trial of adjunctive levetiracetam in pediatric partial seizures.
    Glauser TA; Ayala R; Elterman RD; Mitchell WG; Van Orman CB; Gauer LJ; Lu Z;
    Neurology; 2006 Jun; 66(11):1654-60. PubMed ID: 16641323
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Catatonia induced by levetiracetam.
    Chouinard MJ; Nguyen DK; Clément JF; Bruneau MA
    Epilepsy Behav; 2006 Feb; 8(1):303-7. PubMed ID: 16249124
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Efficacy and safety of levetiracetam for outpatient alcohol detoxification.
    Müller CA; Schäfer M; Schneider S; Heimann HM; Hinzpeter A; Volkmar K; Förg A; Heinz A; Hein J
    Pharmacopsychiatry; 2010 Jul; 43(5):184-9. PubMed ID: 20503149
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Tolerability and efficacy of oral loading of levetiracetam.
    Koubeissi MZ; Amina S; Pita I; Bergey GK; Werz MA
    Neurology; 2008 May; 70(22 Pt 2):2166-70. PubMed ID: 18505995
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The safety and tolerability of different intravenous administrations of levetiracetam, bolus versus infusion, in intensive care unit patients.
    Burakgazi E; Bashir S; Doss V; Pellock J
    Clin EEG Neurosci; 2014 Apr; 45(2):89-91. PubMed ID: 24357676
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Efficacy and tolerability of high oral doses of levetiracetam in children with epilepsy.
    Obeid M; Pong AW
    Epilepsy Res; 2010 Sep; 91(1):101-5. PubMed ID: 20663645
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Levetiracetam induced interstitial nephritis and renal failure.
    Hurwitz KA; Ingulli EG; Krous HF
    Pediatr Neurol; 2009 Jul; 41(1):57-8. PubMed ID: 19520278
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Levetiracetam in a broad population of patients with refractory epilepsy: interim results of the international SKATE trial.
    Genton P; Sadzot B; Fejerman N; Peltola J; Despland PA; Steinhoff B; Rektor I; Wroe S; Maubrey MC; Vandervelden C; van Hammée G; Schlit AF; van Paesschen W
    Acta Neurol Scand; 2006 Jun; 113(6):387-94. PubMed ID: 16674605
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Levetiracetam in the treatment of idiopathic generalized epilepsies.
    Grünewald R
    Epilepsia; 2005; 46 Suppl 9():154-60. PubMed ID: 16302890
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effects of intermittent levetiracetam dosing in a patient with refractory daily seizures.
    Friedman D; French JA
    Neurology; 2006 Feb; 66(4):590-1. PubMed ID: 16505320
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Levetiracetam monotherapy for late poststroke seizures in the elderly.
    Kutlu G; Gomceli YB; Unal Y; Inan LE
    Epilepsy Behav; 2008 Oct; 13(3):542-4. PubMed ID: 18539085
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The SKATE study: interim analysis.
    Olwen GO
    Int J Clin Pract; 2003; 57(6):544-5. PubMed ID: 12918896
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Open label, long-term, pragmatic study on levetiracetam in the treatment of juvenile myoclonic epilepsy.
    Specchio LM; Gambardella A; Giallonardo AT; Michelucci R; Specchio N; Boero G; La Neve A
    Epilepsy Res; 2006 Sep; 71(1):32-9. PubMed ID: 16814521
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.